Catalent | تكلفة المبيعات



Cost Of Sales تغيير تاريخ
Agilent USD 802M 20M 2025-04
AstraZeneca USD 2.24B 484M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Bruker USD 410.2M 76.1M 2025-03
Centene USD 41.42B 4.33B 2025-03
Charles River Laboratories USD 666.44M 16.43M 2025-03
Cigna USD 58.9B 291M 2025-03
Danaher USD 2.23B 418M 2025-03
Dentsply International USD 413M 37M 2025-03
Elevance Health 33.5B 551M 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Hologic USD 444.6M 3.3M 2025-03
Humana 25.38B 24.75B 2024-12
Illumina USD 358M 18M 2025-03
Intuitive Surgical USD 795.7M 24.4M 2025-03
IQVIA Holdings USD 2.53B 49M 2025-03
J&J USD 7.3B 189M 2025-03
Laboratory Of America USD 2.4B 36M 2025-03
Lonza CHF 2.47B 532M 2024-12
McKesson USD 87.44B 4.6B 2025-03
Merck EUR 2.14B 184M 2025-03
Merck USD 2.76B 944M 2025-03
Mettler Toledo International USD 357.86M 47.95M 2025-03
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Quest Diagnostics USD 1.79B 26M 2025-03
Repligen USD 78.41M 8.82M 2025-03
Revvity USD 289.22M 27.87M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Thermo Fisher Scientific USD 6.06B 517M 2025-03
UnitedHealth 79.5B 1.71B 2024-12
Waters USD 276.74M 71.77M 2025-03
West Pharmaceutical Services USD 466.1M 9.1M 2025-03



Catalent تكلفة المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.